TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Occurrence of solicited systemic AEs during 7 days post each vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of unsolicited AEs during 28 days post each vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Serious Adverse Events (SAEs), Medically Attended Adverse Events (MAAEs) and Adverse Events of Special Interest (AESIs) during the whole study period
Endpoint domain: Adverse events/effects
Primary endpoint: Hypercoagulability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of composite endpoint (sternum instability, sternum dehiscence, sternal wound infection)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in usage of rescue inhalers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Relative hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under Concentration-time Curve From Time Zero to Infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in retentive force of the complete denture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in occlusal forces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BREASTQ
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in surface markers of eosinophils and eosinophil subpopulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in medium-low abundant serum proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants' understanding of respiratory infections and associated risks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participants' understanding regarding vaccinations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participants' views about perceived benefits and risks of vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients with Osteoporosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Difference in PEEP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Homeostatic model assessment (HOMA-IR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in finger temperature measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in tissue Oximetry measure for each finger
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dermal irritation (erythema) potential
Endpoint domain: Adverse events/effects
Primary endpoint: dermal sensitization potential
Endpoint domain: Adverse events/effects
Primary endpoint: cumulative irritation potential
Endpoint domain: Adverse events/effects
Primary endpoint: Serum levels of markers of lipid metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Liver lipid content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Whole body protein turnover
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: difference from baseline of aortic arch anomalies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Two-years disease free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative rate of biliopancreatic events development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: % Adequate adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Completion of screening for Type 2 Diabetes Mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: remineralizing effect on deep caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Detection of stroke patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: % time spent in target glucose range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Exercise sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinesiophobia for Heart Disease
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of CSF white cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Safety of Investigational Medical Device
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with ototoxic hearing loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver-Reported Rating of Feeding Experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under curve (AUC) from time zero to 48 hours post dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak plasma concentration (Cmax) for nirmatrelvir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour pad test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in ALB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of gingival recession associated to abfraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of the volume of gingiva at the level of the gingival margin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of Caffeine, Flurbiprofen, Omeprazole, Metoprolol, and Midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration (Cmax) of Caffeine, Flurbiprofen, Omeprazole, Metoprolol, and Midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: iron metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ICIQ-SF score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinician-Administered PTSD Scale (CAPS-5)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PTSD Checklist (PCL-5)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of Life in Reflux and Dyspepsia (QOLRAD)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ABILHAND-kids Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Motivation to Learn Medical Terminology
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in clinical assessment of efficacy items
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of lactational mastitis
Endpoint domain: Adverse events/effects
Primary endpoint: nausea and vomiting evaluation and quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in EELV (End Expiratory Lung Volume)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cmax of Vorasidenib (substudy A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of Vorasidenib (substudy A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of Vorasidenib (substudy A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-inf of Vorasidenib (substudy A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Vorasidenib (substudy B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gynaecological Reconstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change From Baseline in TETRAS Performance Subscale Item 4 Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change from baseline Sino-Nasal Outcome Test (SNOT-22) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in the number of acute rhinosinusitis infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: World Health Organization Quality of Life - BREF version (WHOQOL-BREF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oswestry Disability Index (ODI2.1a)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Average Confidence Difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Mratio Difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual hearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sulcus depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of Safety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in tremor power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peripheral muscle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Daily living activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of patients able to have vaginal penetration without pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in cervical cancer specific quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Expression of the trop-2 in the tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Uptake of the dye by the tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: False positive rates of ICG-SG
Endpoint domain: Adverse events/effects
Primary endpoint: Axial length shortening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One-year Progression Free Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Change in breastfeeding self-efficacy score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in spectral edge frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in density spectral array
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of convulsive activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postictal suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Need for restimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fugl Meyer Assessment of Motor Recovery after Stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuro Quality of Life Upper Extremity Short Form test
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: BBB function repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood serum S100β levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of disability and symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Assessment of pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: serum Visfatin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum Vaspin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Usability of Quick Reference Instruction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patella positioning in the trochlear groove
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Diabetes Care Gaps
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants with DLTs (Dose Limiting Toxicities)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Best Overall Response Rate in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants with abnormal drug-related safety blood tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Compliance and tolerability of ADX-629
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of specific proteins on CTCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: RBC-TI rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in size of plantar wart
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: change in number of plantar warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: High-Density Lipoprotein (HDL) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Low-Density Lipoprotein (LDL) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: labial gap dimension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity-specificity of Argonaute (AGO) antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in bothersomeness of Tinnitus
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Number of Different Vegetables Consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Diet Quality - Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Diet Quality - Quantity of Serving
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of patients with fluorescence-positive primary tumor biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: True positive rate of fluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: True negative rate of fluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in post-contractile BOLD response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in post-exercise hyperemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum standardised uptake value [SUVmax] for primary lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best diagnostic imaging time of 68GaFAPI-46 PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: opioid dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of third/fourth level neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of patients with at least 50% pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral hypoxic burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants developing anti-BDB-001 antibodies
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of BDB-001
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Caregivers Skills and Knowledge Measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative Stent Patency Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Acute Mountain Sickness (AMS) Incidence
Endpoint domain: Adverse events/effects
Primary endpoint: General concordance between results for cfDNA in SCM and trophectoderm biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of niPGT-A using cfDNA in SCM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of niPGT-A using cfDNA in SCM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily symptom self-report completion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Site adoption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improved palliative care access
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Changes in perceived level of disability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in physical quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Portal Vein Recanalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Accuracy of STANDING algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Specificity of the 5-SENSE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity of the 5-SENSE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Positive predictive value of the 5-SENSE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Negative predictive value of the 5-SENSE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean score Beck's Scale for Suicidal Ideation (BSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of any suicidal behaviors measured by the Columbia Suicide Severity Rating Scale (CSSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Late gastrointestinal (GI) toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Progression-free survival rate (PFSR) at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Diagnostic accuracy of wearable based physiological data in detecting dysglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in HbA1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Experience at least one Adverse Event of Interest (AEI)
Endpoint domain: Adverse events/effects
Primary endpoint: Experience at least one Serious Adverse Event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Antibody level of BMS-986414 in plasma/serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibody level of BMS-986413 in plasma/serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurological outcome 90 days after the stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: body mass index (derived)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip Disability and OA Outcome Score (HOOS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient Global Assessment of Health Status (PGA)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in Youth Outcomes Questionnaire Self-Report (YoQ-SR)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in Family Assessment Device (FAD)
Endpoint domain: Life impact
Endpoint subdomain: Family functioning
Primary endpoint: Change from Baseline in Adolescent Alcohol Relapse Coping Questionnaire (ARCQ)
Endpoint domain: Life impact
Endpoint subdomain: Coping strategies
Primary endpoint: Anxiety levels measured by the Beck Anxiety Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stress levels measured by the Perceived Stress Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety levels measured by Spielberger's state-trait anxiety test
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in MGS score for the worse eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity over 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of radiolabelled siderophore (68Ga-TAFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 6-item CTS Symptom Scale (CTS-6)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The Michigan Hand Outcomes Questionnaire (MHQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of patients with AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Motor evoked potential (MEP) potentiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difference in gastric volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes